GL

Guirec Le Lous

Active Director Director DIN 08620215
DIN 08620215 First appointment Nov 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Guirec Le Lous

Data last updated:

Guirec Le Lous is a Director at Eucare Pharmaceuticals P Ltd (since 2019). The company operates in Pharma. Eucare Pharmaceuticals P Ltd reported revenue of ₹38.35 Cr (FY 2026).

DIN 08620215
Primary Designation Director
Industry Pharma
First Appointment 25 Nov 2019
Oldest Company Age 30 yrs
Largest company Eucare Pharmaceuticals P Ltd · ₹38.35 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eucare Pharmaceuticals P Ltd U24231TN1996PTC034848
Director25 Nov 20191996₹38.35 Cr (FY 2026)Active

Board colleagues of Guirec Le Lous

Directorship timeline

Open interactive timeline →
Eucare Pharmaceuticals P Ltd
Premium access

Shareholding and investment profile for Guirec Le Lous

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Guirec Le Lous

Guirec Le Lous currently holds 1 directorship: Eucare Pharmaceuticals P Ltd (Director, since 25 Nov 2019, revenue ₹38.35 Cr (FY 2026)).

Guirec Le Lous was first appointed on 25 Nov 2019 as Director at Eucare Pharmaceuticals P Ltd.

The current boards of Guirec Le Lous's companies include Gavin John Ashton (Eucare Pharmaceuticals P Ltd), Javier Camps Hernan Perez (Eucare Pharmaceuticals P Ltd), Pratik Santosh Bhide (Eucare Pharmaceuticals P Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available